Lyra Ditches Sole Rhinosinusitis Asset, Lays Off All Employees
13 Jan 2026 //
FIERCE BIOTECH
Lyra Therapeutics Provides Corporate Update
12 Jan 2026 //
GLOBENEWSWIRE
Lyra Pharma Reveals LYR-210 Clinical Strategy & ENLIGHTEN 2 Study
06 Oct 2025 //
GLOBENEWSWIRE
Lyra Reports Topline Phase 3 LYR-210 Chronic Sinusitis Data
06 May 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support